Hamidreza Ghasemirad | Medicine and Dentistry | Young Researcher Award

Published on by Invention Awards

Young Researcher Award

Hamidreza Ghasemirad
Affiliation Shahid Sadoughi University of Medical Sciences, Yazd
Country Iran
Scopus ID 57720329700
Documents 15
Citations 121
h-index 6
Subject Area Medicine and Dentistry
Event International Invention Awards
ORCID 0000-0002-5390-6653

Hamidreza Ghasemirad

Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Hamidreza Ghasemirad is an emerging researcher affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, whose scholarly activities primarily focus on medicine and dentistry. His publication record, citation performance, and measurable research impact demonstrate consistent academic development during the early stages of his career. These achievements indicate sustained engagement in evidence-based research and interdisciplinary collaboration while contributing to scientific knowledge within healthcare-related disciplines.[1]

Abstract

Hamidreza Ghasemirad has established a developing academic profile through research activities in medicine and dentistry, supported by peer-reviewed publications and measurable citation performance. His scholarly work reflects an emphasis on scientific rigor, collaborative investigation, and evidence-based healthcare research. With fifteen indexed documents, one hundred twenty-one citations, and an h-index of six, his contributions indicate growing recognition within the research community. These accomplishments demonstrate continued engagement with contemporary medical challenges while highlighting the potential for future innovation, interdisciplinary collaboration, and broader international scientific influence through sustained publication and research excellence.[1][2]

Keywords

Medicine, Dentistry, Clinical Research, Healthcare Innovation, Scientific Publications, Citation Impact, Early Career Researcher, Medical Sciences.

Introduction

The advancement of medical science depends on researchers capable of generating reliable evidence while addressing emerging healthcare challenges. Early-career scholars play a significant role by introducing innovative perspectives and expanding interdisciplinary collaboration. Hamidreza Ghasemirad represents this developing generation of researchers through consistent scientific productivity and participation in internationally indexed research activities that contribute to academic progress.[2]

Research Profile

Affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, Hamidreza Ghasemirad has developed a research portfolio centered on medicine and dentistry. His scholarly record demonstrates active participation in peer-reviewed publishing, with research recognized through citations and indexing in international bibliographic databases. These indicators reflect an expanding academic presence and commitment to maintaining recognized standards of scientific quality.[1]

Research Contributions

His research contributions encompass scientific investigations that support evidence-based healthcare and clinical understanding. Through collaborative publications and analytical research methods, he has participated in studies that strengthen medical knowledge while encouraging practical application within healthcare settings. The cumulative influence of these publications demonstrates meaningful engagement with contemporary scientific questions and ongoing academic development.[3]

Publications

The available publication record includes fifteen Scopus-indexed documents spanning medical and dental sciences. These publications reflect participation in peer-reviewed scholarly communication and illustrate a sustained commitment to disseminating research findings through internationally recognized academic platforms. Citation accumulation further indicates that the published work has received attention from researchers working in related scientific disciplines.[1][4]

Research Impact

Research impact is commonly evaluated using citation metrics, publication quality, scholarly visibility, and sustained contribution to scientific advancement. Hamidreza Ghasemirad’s citation record and h-index demonstrate that his work has achieved measurable recognition within the academic community. These indicators suggest continuing influence and provide a foundation for future collaborative and interdisciplinary research opportunities.[2]

Award Suitability

Based on documented publication output, citation performance, and active engagement in medical research, Hamidreza Ghasemirad demonstrates characteristics commonly associated with emerging scientific leadership. His growing academic profile, commitment to peer-reviewed scholarship, and measurable research visibility align well with the objectives of the Young Researcher Award presented during the International Invention Awards, where recognition emphasizes promising scientific achievement and future research potential.[5]

Conclusion

Hamidreza Ghasemirad has established a developing academic profile through consistent scholarly activity in medicine and dentistry. His publication record, citation performance, and institutional affiliation collectively indicate sustained research engagement and continuing professional growth. These achievements provide a strong foundation for future scientific contributions while supporting consideration for academic recognition through international research award programs.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Hamidreza Ghasemirad, Author ID 57720329700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57720329700
  2. ORCID. (n.d.). ORCID Record: Hamidreza Ghasemirad.
    https://orcid.org/0000-0002-5390-6653
  3. Pharmaceutical and Biomedical Research. (2025). Clinical and Prognostic Findings in Psychotropic Substance Poisoning: A Cross-sectional Study.
    https://doi.org/10.32598/pbr.11.3.1366.1
  4. Molecular and Cellular Biochemistry. (2023). The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer.
    https://doi.org/10.1007/s11010-023-04790-4
  5. International Invention Awards. (n.d.). Award Information and Recognition Program.
    https://inventionawards.org/

Tahir Turk | Health Professions | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Tahir Turk
Dow University of Health Sciences, Australia

Tahir Turk
Affiliation Dow University of Health Sciences
Country Australia
Scopus ID 37091848000
Documents 20
Citations 278
h-index 9
Subject Area Health Professions
Event International Invention Awards
ORCID 0000-0002-8119-4171

Tahir Turk is a researcher associated with Dow University of Health Sciences whose scholarly activities focus on public health, health promotion, nutrition-sensitive social protection, social and behaviour change communication (SBCC), and water, sanitation and hygiene initiatives. His publication record demonstrates engagement with evidence-based interventions designed to improve health outcomes in diverse communities and low- and middle-income country settings. Through interdisciplinary collaborations, his work contributes to the understanding of behavioural determinants of health and the development of context-specific communication strategies.[1]

Abstract

This article reviews the academic profile of Tahir Turk and highlights contributions to public health research, nutrition-sensitive interventions, behavioural communication strategies, and WASH-related initiatives. His publications demonstrate a commitment to co-design methodologies, systematic evidence synthesis, and community-centered health promotion. The body of work reflects practical applications of behavioural science within public health programs and supports the advancement of effective communication frameworks for improving population health outcomes.[2]

Keywords

Public Health, Health Promotion, Social and Behaviour Change Communication, Nutrition, WASH, Community Engagement, Co-design Research, Systematic Review.

Introduction

Modern public health challenges increasingly require integrated approaches that combine behavioural science, community participation, and evidence-informed interventions. Tahir Turk’s research addresses these priorities through studies examining nutrition-sensitive social protection programs, obesity prevention strategies, and sanitation-related behavioural change initiatives. His work contributes to contemporary discussions regarding the implementation and evaluation of public health communication programs.[3]

Research Profile

According to available scholarly metrics, Tahir Turk has authored twenty indexed publications, accumulating 278 citations and an h-index of 9. His primary subject classification falls within Health Professions, with interdisciplinary engagement across public health, nutrition, health communication, and implementation research. The research portfolio demonstrates sustained attention to improving health outcomes through participatory and culturally informed intervention models.[1]

Research Contributions

  • Development of co-designed WASH communication strategies in Kiribati.
  • Systematic review of social and behaviour change communication interventions within nutrition-sensitive social protection programs.
  • Integration of co-design methodologies into formative research frameworks for low- and middle-income countries.
  • Research supporting obesity prevention communication strategies in Pacific Island contexts.

Publications

  • Co-designing water sanitation and hygiene (WASH) messages for a social and behaviour change campaign in Kiribati (2026).
  • Effect of Integrating Social and Behavior Change Communication Strategies in Nutrition-Sensitive Social-Protection Programs on Specific Nutritional Outcomes: A Systematic Review (2026).
  • Integrating co-design into formative research for a SBCC entry-point platform for nutrition-sensitive social protection programs (2025).
  • Conducting formative research during a pandemic threat to inform obesity prevention communication strategies in Tonga (2024).

Research Impact

The impact of Turk’s scholarship is reflected in its emphasis on practical implementation and community engagement. His studies support policymakers, public health practitioners, and development organizations seeking evidence-based approaches to behavioural change and nutrition improvement. The combination of systematic reviews, formative research, and co-design methods strengthens the applicability of findings across diverse health settings.[4]

Award Suitability

Tahir Turk’s contributions align with the objectives of the International Invention Awards by demonstrating innovation in health communication, participatory research design, and public health intervention development. The integration of behavioural science principles into real-world health programs illustrates scholarly originality and practical relevance. His research record provides evidence of sustained academic productivity and measurable scholarly influence within the field of health professions.[5]

Conclusion

The academic profile of Tahir Turk highlights a focused commitment to advancing public health through behavioural communication research, nutrition-sensitive programming, and participatory intervention design. His body of work contributes valuable insights for researchers and practitioners working to improve health outcomes through evidence-based and community-centered approaches.

References

  1. Elsevier. (n.d.). Scopus author details: Tahir Turk, Author ID 37091848000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37091848000
  2. Public Health in Practice. (2026). Co-designing water sanitation and hygiene (WASH) messages for a social and behaviour change campaign in Kiribati.
    DOI: https://doi.org/10.1016/j.puhip.2026.100821
  3. Nutrition Reviews. (2026). Effect of Integrating Social and Behavior Change Communication Strategies in Nutrition-Sensitive Social-Protection Programs on Specific Nutritional Outcomes.
    DOI: https://doi.org/10.1093/nutrit/nuaf063
  4. PLOS One. (2025). Integrating co-design into formative research for a SBCC entry-point platform.
    DOI: https://doi.org/10.1371/journal.pone.0310288
  5. Health Promotion Journal of Australia. (2024). Conducting formative research during a pandemic threat to inform the development of an obesity prevention strategy in Tonga.
    DOI: https://doi.org/10.1002/hpja.821
  6. medRxiv Preprint. (2024). Integrating co-design into formative research for nutrition-sensitive social protection programs.
    DOI: https://doi.org/10.1101/2024.09.08.24313037

Leticia Szadai | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Leticia Szadai
Lund University, Sweden

Leticia Szadai
Affiliation Lund University
Country Sweden
Google Scholar ID CNcrXOIAAAAJ
Documents 27
Citations 175
h-index 7
Subject Area Medicine and Dentistry
Event International Invention Awards

The Best Researcher Award recognizes researchers whose scholarly activities have contributed to the advancement of knowledge and innovation within their respective disciplines. Leticia Szadai of Lund University has developed a research profile centered on melanoma biology, proteomics, biomarker discovery, and translational cancer research. Her work integrates advanced molecular analysis with clinical applications, supporting improved understanding of melanoma progression, recurrence mechanisms, and therapeutic opportunities. Through collaborative research efforts, she has contributed to the generation of valuable datasets and analytical frameworks relevant to modern oncology research.[1]

Abstract

This article summarizes the academic achievements and research contributions of Leticia Szadai. Her work primarily focuses on melanoma proteomics, molecular pathology, biomarker identification, and translational oncology. Through participation in multidisciplinary investigations, she has contributed to the development of proteomic resources and analytical methods that support precision medicine approaches in cancer research.[2]

Keywords

Melanoma, Proteomics, Molecular Pathology, Biomarkers, Translational Medicine, Cancer Research, Precision Oncology, Tumor Biology.

Introduction

Advances in cancer research increasingly depend on interdisciplinary methodologies that connect molecular science with clinical practice. Leticia Szadai has contributed to this field through studies examining melanoma biology and the molecular factors associated with disease progression and recurrence. Her research reflects contemporary efforts to improve diagnostic and prognostic strategies through large-scale proteomic investigation.[3]

Research Profile

As a researcher affiliated with Lund University, Leticia Szadai has participated in projects involving molecular oncology, clinical proteomics, and translational medicine. Her publication record demonstrates engagement with collaborative international research initiatives focused on melanoma tissue analysis, mitochondrial regulation, immune response mechanisms, and biomarker discovery. These efforts contribute to the broader objective of enhancing evidence-based cancer management.[4]

Research Contributions

  • Contributed to studies establishing comprehensive melanoma proteome atlases.
  • Investigated molecular pathology and protein expression patterns in melanoma.
  • Explored mitochondrial dysfunction and immune response dysregulation associated with melanoma recurrence.
  • Participated in biomarker discovery using archived tumor samples and advanced proteomic technologies.
  • Supported research into kinase signaling pathways and translational applications in oncology.

Publications

  • The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome (2021).
  • The Human Melanoma Proteome Atlas—Defining the Molecular Pathology (2021).
  • Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence (2023).
  • Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out (2021).
  • A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma (2021).

Research Impact

The available citation metrics indicate that Leticia Szadai’s research outputs have attracted scholarly attention within oncology and translational medicine communities. Her involvement in high-impact collaborative studies has supported the development of proteomic resources that facilitate future investigations into melanoma progression, biomarker validation, and personalized therapeutic strategies. These contributions demonstrate measurable academic influence and continuing relevance to cancer research.[5]

Award Suitability

Leticia Szadai’s research portfolio aligns with the objectives of the International Invention Awards and the Best Researcher Award category. Her scholarly contributions reflect innovation in proteomic methodology, translational cancer research, and biomarker development. The combination of publication activity, collaborative leadership, and clinically relevant outcomes supports recognition for contributions to medicine and dentistry-related scientific advancement.[6]

Conclusion

Leticia Szadai has established a research profile characterized by rigorous investigation of melanoma biology and proteomics. Her contributions to translational oncology, biomarker discovery, and molecular pathology have supported scientific understanding of cancer mechanisms and potential clinical applications. These achievements provide a strong foundation for academic recognition through the Best Researcher Award.

References

  1. Elsevier. (n.d.). Google Scholar author details: Leticia Szadai
    https://scholar.google.com/citations?hl=hu&user=CNcrXOIAAAAJ
  2. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.451
  3. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Defining the Molecular Pathology. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.473
  4. Szadai L et al. (2023). Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.1495
  5. Szadai L et al. (2021). Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out. Cancers.
    https://doi.org/10.3390/cancers13236105
  6. Velasquez E et al. (2021). A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.466

A. Marcell Szasz | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards

Excellence in Research Award

A. Marcell Szasz
Semmelweis University, Hungary

A. Marcell Szasz
Affiliation Semmelweis University
Country Hungary
Scopus ID 24723204500
Documents 147
Citations 4,107
h-index 29
Subject Area Medicine and Dentistry
Event International Invention Awards
Google Scholar ID eeJzLNQAAAAJ

The Excellence in Research Award recognizes researchers whose scholarly activities demonstrate sustained contributions to scientific advancement, interdisciplinary collaboration, and measurable research impact. A. Marcell Szasz of Semmelweis University has developed a notable academic profile in medicine and cancer research through influential publications, biomarker studies, translational oncology investigations, and evidence-based clinical analyses.[1] His publication record and citation performance indicate significant engagement within the international scientific community.[2]

Abstract

A. Marcell Szasz has contributed to the fields of oncology, molecular medicine, prognostic biomarker analysis, and cancer outcome prediction. His research portfolio encompasses gene-expression studies, clinical meta-analyses, cancer progression modeling, and translational medical investigations. Through collaborations with international research teams, his work has informed understanding of disease mechanisms and patient stratification approaches in modern oncology.[2]

Keywords

Oncology, Biomarkers, Precision Medicine, Cancer Research, Meta-analysis, Gene Expression, Translational Medicine, Clinical Research.

Introduction

Research excellence is frequently evaluated through scientific influence, publication quality, citation impact, and contribution to knowledge development. Within this context, A. Marcell Szasz has established a scholarly presence through studies addressing cancer biology, prognostic biomarkers, and therapeutic outcomes. His work contributes to evidence-based approaches used in clinical and translational medicine.[3]

Research Profile

The researcher maintains a substantial publication portfolio consisting of 147 indexed documents, more than 4,100 citations, and an h-index of 29. His academic activity is primarily associated with medicine, oncology, pathology, molecular diagnostics, and clinical outcome assessment. These metrics reflect both productivity and sustained visibility within international scientific literature.[1]

Research Contributions

  • Investigation of microRNA regulation and metastatic progression in breast cancer.
  • Development and validation of transcriptomic biomarkers associated with survival outcomes.
  • Comprehensive meta-analyses supporting clinical decision-making in oncology.
  • Studies examining genomic alterations and evolutionary pathways of metastatic disease.

Publications

Among his most cited publications are studies on miR-31 and breast cancer metastasis, transcriptomic biomarker validation in gastric cancer, urachal carcinoma meta-analysis, tamoxifen-response biomarkers, and phylogenetic analyses of metastatic progression.[4] These works have received substantial scholarly attention and have been referenced extensively in subsequent research.

Research Impact

The citation performance associated with A. Marcell Szasz demonstrates broad engagement from researchers across oncology, pathology, molecular biology, and clinical medicine. His publications have contributed to methodological refinement, biomarker validation, and evidence synthesis efforts that support future investigations and clinical translation.[5]

Award Suitability

The Excellence in Research Award emphasizes scientific rigor, research influence, and sustained scholarly contribution. Based on publication metrics, citation impact, interdisciplinary collaborations, and documented contributions to cancer research, A. Marcell Szasz demonstrates characteristics commonly associated with distinguished academic achievement and research leadership.[6]

Conclusion

A. Marcell Szasz has contributed meaningfully to contemporary oncology research through studies addressing biomarkers, disease progression, and clinical outcomes. His publication record, citation profile, and participation in influential collaborative projects provide a strong foundation for recognition within an academic award framework focused on research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: A. Marcell Szasz, Author ID 24723204500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24723204500
  2. Valastyan S., Reinhardt F., et al. (2009). miR-31 inhibits breast cancer metastasis. Cell.
    DOI: https://doi.org/10.1016/j.cell.2009.03.047
  3. Szász A.M., Lánczky A., et al. (2016). Cross-validation of survival associated biomarkers in gastric cancer. Oncotarget.
    DOI: https://doi.org/10.18632/oncotarget.10337
  4. Brown D., Smeets D., Székely B., Szasz A.M., et al. (2017). Phylogenetic analysis of metastatic progression in breast cancer. Nature Communications.
    DOI: https://doi.org/10.1038/ncomms14944
  5. Mihály Z., Kormos M., Lánczky A., et al. (2013). Gene expression-based biomarkers predicting outcome after tamoxifen treatment.
    DOI: https://doi.org/10.1007/s10549-013-2619-y
  6. Szarvas T., Módos O., Niedworok C., et al. (2016). Clinical, prognostic, and therapeutic aspects of urachal carcinoma.
    DOI: https://doi.org/10.1016/j.urolonc.2016.04.012

Ana Maria Mihai | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards
After Completing the Registration Process, your Biography will be displayed here.

Register by using your Entry ID: 26242

Register Here

 

Maryam AlQannas | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards
After Completing the Registration Process, your Biography will be displayed here.

Register by using your Entry ID: 26239

Register Here

 

Sana Loubbairi | Health Simulation | Women Researcher Award

Published on by Invention Awards

Ms. Sana Loubbairi | Health Simulation | Women Researcher Award

PhD Candidate in Ibn Zohr University, Morocco

Ms. Sana Loubbairi is a PhD researcher in health simulation at the Faculty of Medicine and Pharmacy of Agadir, Morocco, holding a Master’s degree in Advanced Health Care from ISSS Settat and a Bachelor’s degree in Nursing with a specialization in Anesthesia and Resuscitation from ISPITS Agadir. She serves as a workshop facilitator in basic nursing care at FMP Agadir and as a part-time lecturer at ISPITS Agadir, delivering theoretical courses, supervising practical sessions, and participating in student evaluations. Her research focuses on simulation-based medical education, critical thinking, reflective practice, and artificial intelligence in healthcare training. She has published systematic reviews and comparative studies on high-fidelity simulation, standardized patients, and AI-driven simulation in medical and nursing education. Her complementary training includes Clinical Simulation Essentials and Masterclass for Simulation Trainers, Artificial Intelligence in Healthcare, Clinical Trials and Research, Simulation Center Evaluation by Sofrasim, and Statistical Analysis using Jamovi.

Citation Metrics (Scopus)

200
150
100
50
10
0

Citations
169

Documents
20

h-index
7

Citations

Documents

h-index

View Scopus Profile View Orcid Profile

Featured Publications

Magdalena Sobieska | Physiotherapy | Research Excellence Award

Published on by Invention Awards

Prof. Magdalena Sobieska | Physiotherapy | Research Excellence Award

Prof. Magdalena Sobieska | Poznań University of Medical Sciences | Poland

Dr. Magdalena Sobieska is a distinguished rehabilitation and physiotherapy specialist at the Poznań University of Medical Sciences, widely recognized for her deep expertise in immunology, clinical diagnostics, and physical medicine. She has held influential academic and leadership roles that have significantly strengthened physiotherapy education, clinical practice, and international program development within her institution. A prolific and impactful researcher, Dr. Sobieska has contributed substantially to multiple domains intersecting immunology and rehabilitation. Her scientific work encompasses the study of acute phase proteins as sensitive indicators of immune activation following physical exercise, stress, and physiotherapeutic interventions. She has also advanced understanding of eosinophil activation mechanisms and the diagnostic utility of cytokines and acute phase proteins in traumatic injuries, pediatric food allergies, inflammatory bowel disease, and melanoma. Her earlier investigations examined immune system dysfunctions in mental disorders, inflammation-related biomarkers in metabolic diseases, and the application of immunodiagnostic monitoring in veterinary medicine. Furthermore, her research has enriched knowledge of rheumatic diseases through the analysis of inflammatory markers and glycosylation profiles. International training at leading immunology and rheumatology centers strengthened her expertise in how physiotherapy modulates inflammation and acute phase responses. Dr. Sobieska maintains an extensive teaching portfolio, encompassing immunology, biochemistry, sport immunology, spa medicine, diagnostic methods in rheumatology, and laboratory medicine for physiotherapy students. Her commitment to education is reflected in her long-standing mentorship of graduate students, with numerous bachelor’s and master’s theses completed under her supervision. Her scholarly influence is well documented, with 2,189 citations across 1,869 documents, a publication record of 117 scientific works, and an h-index of 20, underscoring the sustained impact of her research within the scientific community. Fluent in multiple European languages, she brings multicultural and multilingual strength to collaboration and academic engagement. Her comprehensive background and broad expertise position her as a respected educator, researcher, and mentor in the medical and rehabilitation sciences.

Profiles: Scopus | Orcid

Featured Publications

Gajewska, E., Surowińska, J., Michalak, M., Gajewski, J., Chałupka, A., Naczk, M., Naczk, A., & Sobieska, M. (2025). The third month’s development predicts the side and oblique sit and walking. Journal of Clinical Medicine, 14, Article 38492. https://doi.org/10.3390/jcm14238492

Pawlak-Andryszczyk, Ż., Andryszczyk, M., & Sobieska, M. (2025). Movements induced by optic flow in relation to HINE. Scientific Reports, 15, Article 20726. https://doi.org/10.1038/s41598-025-20726-y

Bieniaszewska, A., Sobieska, M., & Gajewska, E. (2024). Functional and structural changes in patients with spinal muscular atrophy treated in Poland during 12-month follow-up: A prospective cohort study. Journal of Clinical Medicine, 13(14), 4232. https://doi.org/10.3390/jcm13144232

Bieniaszewska, A., Sobieska, M., Steinborn, B., & Gajewska, E. (2023). Examination of upper limb function and the relationship with gross motor functional and structural parameters in patients with spinal muscular atrophy. Biomedicines, 11(4), 1005. https://doi.org/10.3390/biomedicines11041005

De Mezer, M., Rogaliński, J., Przewoźny, S., Chojnicki, M., Niepolski, L., Sobieska, M., & Przystańska, A. (2023). SERPINA3: Stimulator or inhibitor of pathological changes. Biomedicines, 11(1), 156. https://doi.org/10.3390/biomedicines11010156

Gabriella Teresa Capolupo | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards

Dr. Gabriella Teresa Capolupo | Medicine and Dentistry | Excellence in Research Award

Dr. Gabriella Teresa Capolupo | Università campus bio medico di Roma | Italy

Gabriella Teresa Capolupo is an accomplished surgeon, researcher, and academic with extensive expertise in general, oncological, and digestive surgery. She has built a distinguished career that integrates advanced clinical practice with dedicated teaching and scientific contributions. As a university lecturer and instructor, she actively contributes to academic programs in General Surgery, Urology, Digestive Surgery, Endocrinology and Metabolic Surgery, Emergency Surgery, and Head and Neck Surgery. Her educational roles include formal teaching, clinical tutoring, multidisciplinary course integration, and participation in advanced training initiatives such as postgraduate master programs and summer schools. She also serves as coordinator of the tutoring activities for the School of Specialization in General Surgery, ensuring high-quality mentorship for surgical trainees and supporting their academic and clinical progression. Her academic profile is further strengthened by appointments to evaluation bodies, including doctoral examination committees in translational medicine and oncology. Clinically, Dr. Capolupo’s work is rooted in continuous service at a major university hospital, where she has operated within colorectal, general, and geriatric surgery units. She performs a broad range of surgical procedures with recognized expertise in abdominal oncological surgery using both laparotomic and laparoscopic approaches. Her responsibilities include acting as first surgeon, surgical assistant, and tutor in the operating room, as well as leading emergency surgical teams. She has held roles with functional leadership responsibilities across both permanent and fixed-term appointments. Her research activity is substantial and internationally recognized, with 2,050 citations, 105 scientific documents, and an h-index of 19, reflecting her influence and scholarly impact in the field of surgical sciences. Dr. Capolupo’s professional trajectory demonstrates a strong and consistent commitment to clinical excellence, scientific advancement, and the training of future medical professionals.

Profiles: Scopus | Orcid

Featured Publications

Schiavone, V., Carannante, F., Melone, G., Miacci, V., Costa, G., Taffon, C., Caricato, M., Capolupo, G. T., & Mascianà, G. (2025). Tailoring the management of colonic lipomas: A 10-year experience of surgical and endoscopic resection. Journal of Personalized Medicine, 15(11), 544. https://doi.org/10.3390/jpm15110544

Schiavone, V., Capolupo, G. T., Mascianà, G., Carannante, F., Costa, G., Miacci, V., & Caricato, M. (2025). Non-operative management (NOM) in rectal cancer: Current evidence and future directions. Encyclopedia, 5(4), 165. https://doi.org/10.3390/encyclopedia5040165

Carannante, F., Capolupo, G. T., Barberio, M., Altamura, A., Miacci, V., Scopigno, M. Z., Circhetta, E., Costa, G., Caricato, M., & Viola, M. G. (2024). Evaluation of short-term effects on colorectal surgery elective patients after implementing a patient blood management program: A multicenter retrospective analysis. Journal of Clinical Medicine, 13(15), 4447. https://doi.org/10.3390/jcm13154447

Feola, A., Minotti, C., Marchetti, D., Caricato, M., Capolupo, G. T., Marsella, L. T., & La Monaca, G. (2021). A five-year survey for plastic surgery malpractice claims in Rome, Italy. Medicina, 57(6), 571. https://doi.org/10.3390/medicina57060571

Mascianà, G., Capolupo, G. T., Carannante, F., & Caricato, M. (2019). An omental mass. Any idea? International Journal of Surgery Case Reports, 57, 161–164. https://doi.org/10.1016/j.ijscr.2019.02.019

Catarci, M., Ruffo, G., Borghi, F., Patriti, A., Delrio, P., Scatizzi, M., Mancini, S., Garulli, G., Carrara, A., Pirozzi, F., et al. (2019). Colorectal surgery in Italy: A snapshot from the iCral study group. Updates in Surgery, 71, 515–524. https://doi.org/10.1007/s13304-018-00612-1

Carannante, F., Mascianà, G., Lauricella, S., Caricato, M., & Capolupo, G. T. (2019). Correction to: Skin bridge loop stoma: Outcome in 45 patients in comparison with stoma made on a plastic rod. International Journal of Colorectal Disease, 34(12), 2195–2197. https://doi.org/10.1007/s00384-019-03451-7

Shuying Shen | Health Professions | Excellence in Innovation Award

Published on by Invention Awards

Prof. Shuying Shen | Health Professions | Excellence in Innovation Award 

 Zhejiang University | China

Dr. Shuying Shen is a distinguished research fellow at Sir Run Run Shaw Hospital affiliated with the Medical College of Zhejiang University, where she has established a strong research presence in musculoskeletal biology, molecular regulation, and osteoarthritis pathology. She earned her Ph.D. in Biochemistry and Molecular Biology in 2017 and her Bachelor’s degree in Applied Bioscience in 2012, both from Zhejiang University. Dr. Shen’s research has been continuously supported by major competitive grants, including the National Natural Science Foundation of China Excellent Young Scholars Fund, multiple NSFC General Programs, and the Zhejiang Provincial Outstanding Youth Project. Her funded projects focus on elucidating mechanisms of protein post-translational modification, chondrocyte aging, metabolic reprogramming in osteosarcoma, and non-classical regulatory pathways in chondrocyte physiology, reflecting her deep engagement with both degenerative diseases and cancer biology. Dr. Shen has made influential contributions to the understanding of noncoding RNA functions in osteoarthritis progression, osteosarcoma development and metastasis, and organ size regulation. Her work reveals how circular RNAs, microRNAs, and RNA–protein interactions shape cellular senescence, lipid metabolism, autophagy, and energy homeostasis. She has also advanced knowledge on the interplay between metabolic remodeling and epigenetic regulation in cartilage degeneration. Her publications demonstrate innovative approaches combining molecular biology, functional genomics, epigenetics, and translational models to uncover therapeutic targets for osteoarthritis, intervertebral disc degeneration, and malignancies. Dr. Shen has published 87 peer-reviewed papers, including 50 as first or corresponding author, in top-tier journals such as Nature Aging, Science Translational Medicine, Cell Research, Nature Communications, Annals of the Rheumatic Diseases, PNAS, Advanced Science, Molecular Cancer, Bone Research, and Molecular Therapy. Her research has been cited more than 3,000 times, and she holds an H-index of 37, underscoring her strong scientific influence. Through her pioneering discoveries—such as the regulation of chondrocyte senescence by palmitoylation, the role of fatty acid oxidation in osteoarthritis, circRNA-mediated metabolic control, and noncoding RNA networks in osteosarcoma—Dr. Shen has significantly advanced the field of musculoskeletal molecular medicine. Her long-term research goal is to develop novel diagnostic markers and targeted therapies for osteoarthritis and related degenerative diseases through a deeper understanding of RNA regulation, protein modifications, and metabolic homeostasis.

Profile: Scopus

Featured Publications

Wang, K., He, W., Gong, Z., Gao, J., Gao, T., Pan, N., Wu, D., Yang, Y., Li, Z., Zhao, X., Ji, M., & Shen, S. Y. (2025). ZDHHC11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis. Nature Aging.

Mei, Z., Yilamu, K., Ni, W., Shen, P., Pan, N., Chen, H., Su, Y., Guo, L., Sun, Q., Li, Z., Huang, D., Fang, X., Fan, S., Zhang, H., & Shen, S. Y. (2025). Chondrocyte fatty acid oxidation drives osteoarthritis via SOX9 degradation and epigenetic regulation. Nature Communications, 16(1), 4892.

Gong, Z., Zhu, J., Chen, J., Feng, F., Zhang, H., Zhang, Z., Song, C., Liang, K., Yang, S., Fan, S., Fang, X., & Shen, S. Y. (2023). CircRREB1 mediates lipid metabolism–related senescent phenotypes in chondrocytes through FASN post-translational modifications. Nature Communications, 14(1), 5242.

Li, Z., Zhang, W., Wei, X. Y., Hu, J. Z., Hu, X., Liu, H., Lu, J., Shen, S. Y., & Ji, M. L. (2025). TRIM15 drives chondrocyte senescence and osteoarthritis progression. Science Translational Medicine, 17(791), eadq1735.

Shen, S. Y., Guo, X. C., Yan, H., Lu, Y., Ji, X. Y., Li, L., Liang, T. B., Zhou, D. W., Zhao, J. C., Yu, J. D., Gong, X. G., Zhang, L., & Zhao, B. (2015). A miR-130a–YAP positive feedback loop promotes organ size and tumorigenesis. Cell Research, 25(9), 997–1012.

Shen, S. Y., Wu, Y. Z., Chen, J. X., Xie, Z., Huang, K. M., Wang, G. L., Yang, Y. T., Ni, W. Y., Chen, Z. J., Shi, P. H., Ma, Y., & Fan, S. W. (2019). CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene. Annals of the Rheumatic Diseases, 78(6), 826–836.

Shen, S. Y., Yang, Y. T., Shen, P. Y., Ma, J., Fang, B., Wang, Q. X., Wang, K. F., Shi, P. H., Fan, S. W., & Fang, X. Q. (2021). circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1. Annals of the Rheumatic Diseases, 80(9), 1209–1219.

Shen, S. Y., Liang, Y., Zhao, Y., Hu, Z., Huang, Y., Wu, Y., Liu, Y., Fan, S., Wang, Q., & Xiao, P. (2024). Dietary supplementation of vitamin B1 prevents the pathogenesis of osteoarthritis. Proceedings of the National Academy of Sciences, 121(30), e2408160121.